TCM Syndrome Differentiation Treatment on Discharged Elderly Patients With CAP

• Status: Not yet recruiting
• Trial end date: 2022-12-30
• Target enrollment: 0
• Participant gender: All

Summary

This study is to evaluate the efficacy and safety of TCM syndrome differentiation treatment on the rehospitalization rate of discharged elderly patients with community acquired pneumonia(CAP)and to explore its mechanism.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Henan University of Traditional Chinese Medicine

Criteria

Inclusion Criteria:

1. A confirmed diagnosis of discharged elderly patients with CAP within 1 weeks;

2. Syndrome differentiation meets criteria of syndrome of the lung and spleen qi deficiency and unclean phlegm dampness, Syndrome of qi and yin deficiency and unclean phlegm heat;

3. Age including or above 65 years old;

4. Voluntary treatment, oral medication;

5. With informed consent signed.

Exclusion Criteria:

1. A confirmed diagnosis of discharged elderly patients with severe CAP;

2. Patients with unconscious, dementia or mental disorders;

3. Patients with hydrothorax, bronchiectasis, active pulmonary tuberculosis, pulmonary abscess, chronic obstructive pulmonary disease of GOLD D;

4. Patients with aspiration risk of severe neuromuscular disorders and long-term bedridden;

5. Patients with tumor, severe cardiovascular disease and severe liver and kidney diseases;

6. Participants in clinical trials of other drugs;

7. People who are allergic to the treatment drugs.